Egyptian (CASE/EGX) Pharma Industry Analysis

UpdatedJan 15, 2026

DataAggregated Company Financials

Companies11

7D-3.9%
3M-0.9%
1Y81.6%
YTD-3.8%

Over the last 7 days, the Pharma industry has dropped 3.9%, and Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) contributed the most with a 5.5% decline. This takes the industry's 12 month performance to a gain of 82%. As for the next few years, earnings are expected to grow by 23% per annum.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Thu, 15 Jan 2026	ج.م49.5b	ج.م35.1b	ج.م3.9b	13.8x	12.6x	1.4x
Sat, 13 Dec 2025	ج.م48.6b	ج.م34.7b	ج.م3.8b	14.5x	12.8x	1.4x
Mon, 10 Nov 2025	ج.م50.4b	ج.م33.0b	ج.م3.7b	16.6x	13.6x	1.5x
Wed, 08 Oct 2025	ج.م44.8b	ج.م33.0b	ج.م3.7b	14.3x	12.1x	1.4x
Fri, 05 Sep 2025	ج.م40.0b	ج.م31.2b	ج.م3.4b	13.3x	11.8x	1.3x
Sun, 03 Aug 2025	ج.م34.1b	ج.م29.4b	ج.م3.1b	10.2x	11.1x	1.2x
Tue, 01 Jul 2025	ج.م30.2b	ج.م29.4b	ج.م3.1b	8.4x	9.9x	1x
Thu, 29 May 2025	ج.م30.2b	ج.م27.8b	ج.م2.7b	7.8x	11.2x	1.1x
Sat, 26 Apr 2025	ج.م28.3b	ج.م26.2b	ج.م2.8b	7.9x	10.1x	1.1x
Mon, 24 Mar 2025	ج.م28.1b	ج.م26.2b	ج.م2.8b	8.1x	10x	1.1x
Wed, 19 Feb 2025	ج.م25.5b	ج.م24.0b	ج.م2.5b	9.2x	10.2x	1.1x
Fri, 17 Jan 2025	ج.م23.4b	ج.م23.7b	ج.م2.4b	9.1x	9.9x	1x
Sun, 15 Dec 2024	ج.م24.4b	ج.م23.7b	ج.م2.4b	8.1x	10.3x	1x
Tue, 12 Nov 2024	ج.م24.5b	ج.م22.0b	ج.م2.2b	7x	11.3x	1.1x
Thu, 10 Oct 2024	ج.م22.1b	ج.م22.1b	ج.م2.1b	6.7x	10.3x	1x
Sat, 07 Sep 2024	ج.م19.8b	ج.م22.2b	ج.م2.4b	5.5x	8.1x	0.9x
Mon, 05 Aug 2024	ج.م18.5b	ج.م21.3b	ج.م2.5b	5x	7.5x	0.9x
Wed, 03 Jul 2024	ج.م19.4b	ج.م20.8b	ج.م2.3b	7.1x	8.5x	0.9x
Fri, 31 May 2024	ج.م19.1b	ج.م20.3b	ج.م1.9b	7.6x	10x	0.9x
Sun, 28 Apr 2024	ج.م20.0b	ج.م19.8b	ج.م1.9b	7.8x	10.7x	1x
Tue, 26 Mar 2024	ج.م22.3b	ج.م19.4b	ج.م2.3b	8.7x	9.9x	1.2x
Thu, 22 Feb 2024	ج.م24.3b	ج.م18.5b	ج.م2.4b	10.2x	10.2x	1.3x
Sat, 20 Jan 2024	ج.م19.5b	ج.م16.4b	ج.م2.2b	7.4x	8.9x	1.2x
Mon, 18 Dec 2023	ج.م19.1b	ج.م16.5b	ج.م2.2b	8.7x	8.8x	1.2x
Wed, 15 Nov 2023	ج.م15.2b	ج.م15.4b	ج.م1.9b	7.9x	7.8x	1x
Fri, 13 Oct 2023	ج.م14.2b	ج.م15.4b	ج.م1.9b	5.3x	7.3x	0.9x
Sun, 10 Sep 2023	ج.م14.4b	ج.م15.9b	ج.م2.0b	7.2x	7.1x	0.9x
Tue, 08 Aug 2023	ج.م13.5b	ج.م15.7b	ج.م2.1b	7.5x	6.5x	0.9x
Thu, 06 Jul 2023	ج.م13.9b	ج.م15.6b	ج.م2.1b	7.2x	6.6x	0.9x
Sat, 03 Jun 2023	ج.م13.8b	ج.م16.1b	ج.م2.2b	5.4x	6.2x	0.9x
Mon, 01 May 2023	ج.م14.2b	ج.م16.2b	ج.م2.4b	5.2x	5.9x	0.9x
Wed, 29 Mar 2023	ج.م13.9b	ج.م15.7b	ج.م2.3b	5.2x	6.1x	0.9x
Fri, 24 Feb 2023	ج.م14.3b	ج.م15.7b	ج.م2.3b	5.4x	6.2x	0.9x
Sun, 22 Jan 2023	ج.م15.1b	ج.م15.6b	ج.م2.3b	5.3x	6.6x	1x

Price to Earnings Ratio

6.6x

Sun, 22 Jan 2023

Current Industry PE

Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 12.6x which is higher than its 3-year average PE of 9.2x.

The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.4x.

Past Earnings Growth

The earnings for companies in the Pharmaceuticals industry have grown 20% per year over the last three years.
Revenues for these companies have grown 31% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.